Target intelligence / Profile preview

PIMREG pseudogene 3 (PIMREGP3)

Target
PIMREGP3
Molecular classification
Other
01

Overview

There is no evidence of a characterized gene, protein, or functional product called "PIMREG pseudogene 3." The established gene **PIMREG** (Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator, also known as FAM64A) is a regulatory protein involved in mitotic progression and is upregulated in various cancers[1][2]. However, "PIMREG pseudogene 3" is not cataloged in major gene databases, nor is it featured in research or review literature regarding pseudogenes with regulatory or disease relevance. Pseudogenes are generally copies of protein-coding genes that have lost the potential to code for functional proteins, although some may retain regulatory or rare coding roles[3][5]. There are no data supporting "PIMREG pseudogene 3" as such an entity. **Note:** If you seek information about the functional PIMREG gene itself or general pseudogene biology, further information is available, but for "PIMREG pseudogene 3" specifically, there appears to be a likely naming or data error, or this is a not-well-characterized entity.

Other names
PIMREGP3

Beyond the preview

Go deeper on PIMREG pseudogene 3 (PIMREGP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIMREG pseudogene 3 (PIMREGP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call